Serum prolidase activity in psoriasis patients

Area of Science:

• Biochemistry
• Dermatology
• Clinical Medicine

Background:

• Psoriasis is a chronic inflammatory skin condition.
• Collagen metabolism alterations may play a role in psoriasis.
• Prolidase is an enzyme involved in collagen breakdown.

Purpose of the Study:

• To evaluate serum prolidase activity in psoriasis patients.
• To investigate the influence of gender, BMI, disease severity, duration, and therapy on prolidase activity.
• To explore the relationship between serum nitric oxide (NO·) and prolidase levels in psoriasis.

Main Methods:

• Compared serum prolidase activity and NO· levels between 29 psoriasis patients and 24 healthy controls.
• Assessed demographic data, BMI, disease severity (PASI), duration, and therapy type.
• Measured NO· using the Griess reaction and serum prolidase activity via colorimetric proline determination.

Main Results:

• Serum prolidase levels were significantly higher in psoriasis patients compared to controls.
• No significant differences in prolidase activity were observed based on gender, BMI, PASI, or disease duration.
• Serum NO· levels did not differ between patients and controls, and no correlation with prolidase was found.

Conclusions:

• Psoriasis patients exhibit elevated serum prolidase activity.
• This elevation is independent of gender, BMI, disease severity/duration, or treatment type.
• Further research is needed to confirm these findings and explore implications for collagen synthesis in psoriasis.